在很宽的频率范围仍保持稳定的射频性能 0,0 2,0 4,0 6,0 8,0 10,0 12,0 0 10 20 30 40 50 60 D ie le ct ri c co ns ta nt F requency [GHz ] PR E PE RM® PPE 95 0 PR E PE RM® PPE 80 0 PR E PE RM® PPE 44 0 PR E PE RM® PPE 32 0 PR E PE RM® PPE 26 0 生产过程中批次间的稳定性 * 2018 年芬兰有限公司VTT技术研究中心测量数据 介 电 常 数 损 耗 因 数 介 电 常 数 频率 [GHz] 频率 [GHz] 分批编号 （1250 kg/批次） PREPERM™ PPE950 PREPERM™ PPE800 PREPERM™ PPE440 PREPERM™ PPE320 PREPERM™ PPE260 -- 目标介电常数 -- +/- 2% 3,76 3,78 3,80 3,82 3,84 3,86 3,88 3,90 3,92 3,94 0 1 2 3 4 5 6 7 8 D ie le ct ri c co ns ta nt P a llet number (1250 k g/pa llet ) Die le ctric cons ta nt ta rge t +/- 2 % 0,000 0,002 0,004 0,006 0,008 0,010 0 10 20 30 40 50 60 Lo ss t a ng en t F requency [GHz ] PR E PE RM® PPE 95 0 PR E PE RM® PPE 80 0 PR E PE RM® PPE 44 0 PR E PE RM® PPE 32 0 PR E PE RM® PPE 26 0 0,000 0,002 0,004 0,006 0,008 0,010 0 10 20 30 40 50 60 Lo ss t a ng en t F requency [GHz ] PR E PE RM® PPE 95 0 PR E PE RM® PPE 80 0 PR E PE RM® PPE 44 0 PR E PE RM® PPE 32 0 PR E PE RM® PPE 26 0 0,000 0,002 0,004 0,006 0,008 0,010 0 10 20 30 40 50 60 Lo ss t a ng en t F requency [GHz ] PR E PE RM® PPE 95 0 PR E PE RM® PPE 80 0 PR E PE RM® PPE 44 0 PR E PE RM® PPE 32 0 PR E PE RM® PPE 26 0 1.844.4AVIENT www.avient.com 版权所有©2022 埃万特公司。

Hole diameters should be 1/32" (.8mm) larger in diameter than the diameter of mounting bolts.

Specifically, here are five ways TPEs can help the healthcare industry meet an anticipated capacity crunch: 1.

We offer a wide range of color concentrates for different polymer grades, from standard to engineering polymers, that fulfill the vertical burning (V-0; V-1; V-2) and horizontal burning (HB) tests.

TERMS AND CONDITIONS These Terms and Conditions govern the sale of Products to another (“Buyer”) by Avient Corporation and its affiliates (“Seller”). 1. Kupujúci skontroluje výrobok okamžite po doručení, či nie je 1. Všeobecné obchodné podmienky (1. apríla 2024) Terms and Conditions (April 1, 2024)

WARUNKI Niniejsze Warunki regulują sprzedaż Produktów na rzecz drugiej strony („Kupujący”) przez Avient Corporation i jej podmioty powiązane („Sprzedający”). 1. By making a purchase order to Seller, Buyer confirms the foregoing to Seller. 1. Terms and Conditions (October 1, 2024) Warunki (1 października, 2024 r.)

TERMS AND CONDITIONS These Terms and Conditions govern the sale of Products to another (“Buyer”) by Avient Corporation and its affiliates (“Seller”). 1. Terms and Conditions (December 1, 2024) obligaciones y/o subcontratar la ejecución de las obligaciones del Vendedor en virtud de los presentes Términos sin el consentimiento del Comprador. Términos y Condiciones (1 de diciembre de 2024)

COMPREHENSIVE REGULATORY TESTING AND DOCUMENTATION Raw materials tested to: • ISO 10993-1 and USP , (biological evaluation) • European Pharmacopeia 3.1.3/3.1.5 (polyolefin —materials used for the manufacture of containers) • USP (polyethylene—plastic materials of construction) • ICH Q3D (elemental impurities) We provide Drug Master File (Type III) documentation and other supporting regulatory declarations that are relevant for the application.

ECert - 2023-09-20T092923.129.pdf Page 1 of 7 Validity of this certificate is based on the successful completion of the periodic surveillance audits of the management system defined by the above scope and is contingent upon prompt,written notification to ABS Quality Evaluations, Inc. of significant changes to the management system or components thereof.

General Purposes The general purposes of the Committee are to: • Oversee the Company’s overall executive compensation philosophy and objectives; • Discharge the Board’s responsibilities relating to compensation of the Company’s executive officers (for purposes of this Charter, “executive officers” means the Company’s Section 16 “officers” as defined under Rule 16a-1(f) under the Securities Exchange Act of 1934, as amended); • Assist the Board in the discharge of its fiduciary responsibilities with regard to establishment of policies governing, and the implementation of, all aspects of executive officer compensation throughout the Company, including benefits and perquisites, and compensation for any other employees designated by the Committee for such purposes; • Discharge similar responsibilities with respect to the compensation of non-employee directors; • Review and discuss with management the Company’s disclosures in the Compensation Discussion and Analysis (the “CD&A”) required by rules and regulations of the Securities and Exchange Commission (the “SEC”) and recommend to the Board whether the CD&A should be included in the Company’s proxy statement or other applicable SEC filings; • Prepare a Compensation Committee Report for inclusion in the Company’s applicable filings with the SEC that complies with the rules and regulations of the SEC; and • Provide policy guidance and oversight on significant human resource policies and practices. 2 Duties and Responsibilities The Committee will: Executive Compensation and Incentives. • Oversee and maintain a competitive executive officer compensation program in order to attract and retain qualified executives and to provide incentives to executive officers that reward pay for performance in attaining the Company’s goals and objectives. • Review and approve a peer group of companies to be used for marketplace trend analysis and to assess the competitiveness of the Company’s total compensation opportunities for executive officers. • Review and approve corporate goals and objectives relevant to the Chief Executive Officer’s compensation; in conjunction with the evaluation conducted by the Board as described in the Company’s Corporate Governance Guidelines, evaluate the Chief Executive Officer’s performance in light of these goals and objectives; and determine and approve (or determine and approve, and recommend to the independent members of the Board for their determination and approval) the Chief Executive Officer’s compensation level based on this evaluation and comparable market data provided by an independent compensation consultant. • In determining the long-term incentive component of the Chief Executive Officer’s compensation, consider the Company’s performance and relative shareholder return, the value of similar incentive awards to chief executive officers at comparable companies, and the awards given to the Chief Executive Officer in the past. • Review and approve the compensation of other executive officers of the Company, including benefits and perquisites, taking into consideration the Company’s performance, comparable market data, the performance of each executive officer, and such other factors as may, in the Committee’s discretion, be appropriate. • In evaluating and making recommendations regarding, or determining and approving, executive compensation, the Committee shall consider the results of the most recent shareholder advisory vote on executive compensation (“Say on Pay Vote”) required by Section 14A of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). • With respect to incentive compensation plans and equity-based plans: • Make recommendations to the Board with respect to the approval of incentive compensation plans for executive officers and all equity-based plans. • Review and approve equity-based grants and awards, including long-term incentive plan awards, to officers, senior managers, key employees, and other employees of the Company and its subsidiaries under the Company’s equity-based plans. • Review and approve the performance criteria, target awards, payout criteria and like items for the Company’s long-term incentive compensation plans. • Review and approve (a) attainment levels for executive officers under the Company’s annual incentive plan; (b) payments to executive officers under the annual incentive plan; and (c) payments to executive officers under the Company’s long-term incentive compensation plans. • Administer the Company’s equity-based incentive compensation plans and other plans 3 adopted by the Board that contemplate administration by the Committee. • Review and approve special bonuses and/or other awards to executive officers on a case-by- case basis for outstanding performance. • Review and approve the terms of all employment agreements, management continuity agreements and change in control agreements for elected officers.